1. SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling
- Author
-
Xiaohui Yuan, Tian-Wen Gao, Dao-Pei Zou, Yujie Zhang, Yangmei Chen, Pham Thi Kieu Nguyet, Lingzhao Zhang, Jin Hong Chen, and Adelina Inggawati
- Subjects
0301 basic medicine ,Medicine (General) ,T cell ,Vitiligo ,QH426-470 ,Biochemistry ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Downregulation and upregulation ,Full Length Article ,Genetics ,medicine ,Enhancer ,Molecular Biology ,Transcription factor ,Genetics (clinical) ,MITF ,integumentary system ,Chemistry ,Wnt signaling pathway ,Cell Biology ,Microphthalmia-associated transcription factor ,medicine.disease ,Wnt signaling ,Melanin synthesis ,Cell biology ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Melanocytes ,SFRP5 ,Signal transduction - Abstract
Secreted frizzled-related protein 5 (SFRP5) plays a pivotal role in regulating the development of many tissues and organs, however, as an inhibitor of Wnt signaling, the role of SFRP5 in vitiligo remains unknown. Hence, we speculated that SFRP5 might be associated with melanogenesis in melanocytes by regulating Wnt signaling in vitiligo. In this study, we found that SFRP5 was overexpressed in the skin lesions of patients with vitiligo. Compared with that in normal epidermal melanocytes (PIG1), the expression of SFRP5 was increased in vitiligo melanocytes (PIG3V). To investigate the effect of SFRP5 on melanin synthesis, PIG1 cells were infected with recombinant SFRP5 adenovirus (AdSFRP5), and PIG3V cells were infected with recombinant siSFRP5 adenovirus (AdsiSFRP5). The results showed that SFRP5 overexpression inhibited melanin synthesis in PIG1 cells through downregulation of microphthalmia-associated transcription factor (MITF) and its target proteins via suppression of the Wnt/β-catenin signaling pathway. Accordingly, SFRP5 silencing increased melanin synthesis and activated the Wnt signaling pathway in PIG3V cells. Moreover, SFRP5 overexpression also downregulated the transcriptional activity of T cell factor/lymphoid enhancer factor (TCF/LEF) in PIG1 cells. Furthermore, this inhibitory effect of SFRP5 on melanin synthesis was reversed by treatment with the β-catenin agonist, SKL2001. The inhibitory action of SFRP5 in pigmentation was further confirmed in vivo using a nude mouse model. Hence, our results indicate that SFRP5 can inhibit melanogenesis in melanocytes. Additionally, our findings showed that SFRP5 plays a vital role in the development of vitiligo, and thus may serve as a potential therapeutic target for vitiligo.
- Published
- 2021